Skip to main content
Log in

Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks

  • Original Articles
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

Platelet hyperaggregability was tested in 62 TIA patients by means of the formalin fixing principle of Wu and Hoak. Compared to age-matched controls, the platelet aggregates ratio (PAR) was reduced from 0.99±0.04 SD to 0.807±0.14 SD. This means a highly significant increase of circulating platelet aggregates (CPA) in untreated TIA patients, regardless of the interval sinche the last attack (from 2 days to 1 year). PAR was especially reduced in patients with abnormal angiography (expressing pronounced cerebral or diffuse ATS) and it was possibly affected by previous antiplatelet treatment with ASA.

Sommario

L'iperaggregabilità piastrinica è stata valutata in 62 pazienti affetti TIA mediante il metodo di Wu ed Hoak.

Il confronto con controlli di pari età ha evidenziato un significativo aumento degli aggregati piastrinici circolanti indipendentemente all'epoca dell'ultimo attacco.

I valori di PAR (paltelet aggregates ratio) sono risultati più ridotti nei pazienti con quadri angiografici patologici e più elevati nei malati con precedente terapia con ASA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Agnoli A., Fazio C.:Platelet Aggregation in the Pathogeneses of Cerebrovascular Disorders. Springer-Verlarg Berlin Heidelberg, New York, 1977.

    Google Scholar 

  2. Bansal B.C., Prakash C., Arya R.K., Gulali S.K., Mittal S.C.:Serum Lipids, Platelet and Fibrionolytic Activity in Cerebrovascular Disease. Stroke 9, 137–139, 1978.

    CAS  PubMed  Google Scholar 

  3. Baumgartner H.R., Muggli R., Tschopp T.B., Turitto V.T.:Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thrombos. Haemostas. 35, 124–138, 1976.

    CAS  Google Scholar 

  4. Danta G.:Platelet Aggregation in Patients with Cerebral Vascular Disease and in Control Subjects. Thrombos. Diathes. Haemorrh. 29, 730–732, 1973.

    CAS  Google Scholar 

  5. De Marinis M., Falchetti R., Lorenzetti A., Prencipe M.:Quantificazione degli aggregati piastrinici circolanti: ripetibilità del metodo. Società Italiana di Biologia Sperimentale XLVIII Assemblea Generale. L'Aquila 27–29 September, 1979.

  6. Dougherty J.H., Levy D.E., Weksler B.B.:Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebral vascular disease. Lancet 1, 821–824, 1977.

    PubMed  Google Scholar 

  7. Fields W.S., Lemak N.A., Frankowski R.F., Hhardy R.J.:Controlled Trial of Aspirin in Cerebral Ischemia. Stroke 8, 301–316, 1977.

    CAS  PubMed  Google Scholar 

  8. Fisher C.M.:Observation of Fundus Oculi in Transient Monocular Blindness. Neurology 9, 333–347, 1959.

    CAS  PubMed  Google Scholar 

  9. Gunning A.J., Pickering G.W., Robb-Smith A.H.T., Ross Russel R.W.:Mural thrombosis of the internal carotid artery and subsequent embolism. Quart. J. Med. 33, 155–194, 1964.

    CAS  PubMed  Google Scholar 

  10. Hossmann K.A., Hossmann V.:Coagulopathy following experimental cerebral ischemia. Stroke 8, 249–257, 1977.

    CAS  PubMed  Google Scholar 

  11. Yamazaki H., Takahashi T., Tadahiro S.:Hyperaggregability of platelets in thromboembolic disorders. Thrombos. Diathes. Haemorrh. 34, 94–105, 1975.

    CAS  Google Scholar 

  12. Yon J.L., Anuras S., Wu K.K., andForker E.L.:Granulomatous hepatitis, increased platelet aggregation and hypercholesterolemia. Ann. Intern. Med. 84, 148–150, 1976.

    CAS  PubMed  Google Scholar 

  13. Lenzi G.L., Laghi Pasini F., Vittoria A.:Observations on Platelet Aggregability in the acute phase of untreated strokes. InAgnoli A., Fazio C. (Eds.)Platelet aggregation in the pathogenesis of cerebrovascular disorders. Springer-Verlarg Berlin Heidelberg, New York, pp. 93–95, 1977.

    Google Scholar 

  14. Lowe G.D.O., Reavey M.M., Johnston R.V., Forbes C.D., Prentice C.R.M.:Increased platelet aggregates in vascular and non-vascular illness: Correlation with plasma fibrinogen and effect of ancrod. Thrombos. Res., 14, 377–386, 1979.

    Article  CAS  Google Scholar 

  15. Maca R.D., Fry G.L., Hoak J.C.:New Method for Detection and Quantitation of Circulating Platelet Aggregates. Microvase. Res. 4, 453–457, 1972.

    CAS  Google Scholar 

  16. Mannucci P.M., D'Angelo A., Vigano S., Mari D., Vanasia S., Passetti C., Pareti F.:Sindrome Trombofilica delle Vasculopatie Cerebrali. In Neri Serneri G.G. el al. (eds.) Aterosclerosi e stati trombofilici. 80o Congresso Società Italiana Medicina Interna Palermo 10 October, 1979. Pozzi Roma pp. 525–534, 1979.

  17. Marshall J.:The Management of Cerebrovascular Disease. Blackwell Scientific Pubblication. Oxford-London Edimburgh Melburne, 1974.

    Google Scholar 

  18. Mehta J., Mehta P., Bueger C., Pepine C.J.:Platelet aggregation studies in coronary artery disease. Atherosclerosis 31, 169–175, 1978.

    Article  CAS  PubMed  Google Scholar 

  19. Mustard J.F., Kinlough-Rathbone R.L., Packham M.A.:Recent Status of Research in the Pathogenesis of Thrombosis. Thrombos. Diathes. Haemorrh. Suppl. 59, 157, 1974.

    Google Scholar 

  20. Nachman R.L.:The Platelet as an Inflammatory Cell. InAgnoli A., Fazio C. (eds.).Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders. Springer-Verlarg Berlin Heidelberg, New York, pp. 4–7, 1977.

    Google Scholar 

  21. Nyman D., Kjellin K.G., Mettinger K.L., Siden A., Söderström C.E.:Platelet dysfunction and fibrinolytic insufficiency — potential risk factors in ischaemic cerebrovascular disease. Acta Neurologica Scandinavica Suppl 67 Vol. 57, 252, 1978.

    Google Scholar 

  22. Packam M.A.:Methods for Detection of Hypersensitive Platelets. Philadelphia, June 1977. Thromb. Haemostas 40, 175–195, 1978.

  23. Prazich J.A., Rapaport S.I., Samples J.R., Engler R.:Platelet Aggregate Ratios. Standardization of technique and test results in patients with myocardial ischaemia and patients with cerebrovascular disease. Thrombos. Haemostas 38, 597–605, 1977.

    CAS  Google Scholar 

  24. Prencipe M., Pissarri F.M., Agnoli A.:Platelet aggregation in cerebrovascular Patients. InAgnoli A., Fazio C. (eds.)Platelet aggragation in the pathogenesis of cerebrovascular disorders. Springer-Verlang Berlin, Heidelberg, New York. pp. 129–133, 1977.

    Google Scholar 

  25. Preston F.E., Ward J.D., Marcola B.H., Porter N.R., Timperley W.R., O'Malley B.C.:Elevated B-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1, 238–240, 1978.

    CAS  PubMed  Google Scholar 

  26. Ross Russel R.W.:Obsevations on the retinal blood vessels in monocular blindness. Lancet 2, 1422–1428, 1961.

    Google Scholar 

  27. Sharma S.C., Vijayan G.P., Seth H.N., Suri M.L.:Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in young patients with ischaemic stroke. J. Neurol. Neurosurg. Phychiatr. 41, 118–121, 1978.

    CAS  Google Scholar 

  28. Sherry S.:The role of Platelet in Thrombosis. InCaprino L., Rossi E.C. (eds.)Platelet Aggregation and Drugs. Academic Press, New York, pp. 111–114, 1974.

    Google Scholar 

  29. Stirling Meyer J.:Summary of the Intermational Round Table Conference on Platelet Aggregation in the Pathogenesis of Cerebrovascular Disorders. Stroke 6, 239–244, 1975.

    Google Scholar 

  30. The Canadian Cooperative Study Group:A Randomized Trial of Aspirin and Sulfinpyrazone in threatened stroke. N. Engl. J. Med. 299, 53–59, 1978.

    Google Scholar 

  31. Walsh P'N., Kansu T., Savino P.J.:Platelet activities in arterial occlusive disease of the eye. Stoke 10, 589–594, 1979.

    CAS  Google Scholar 

  32. White A.M., Heptinstall S.:Contribution of platelets to thrombus formation. Br. Med. Bull. 34, 123–128, 1979.

    Google Scholar 

  33. Wu K.K., Hoak J.C.:A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2, 924–926, 1974.

    CAS  PubMed  Google Scholar 

  34. Wu K.K., Hoak J.C.:Increased Platelet Aggregates in patients with Transient Ischemic Attacks. Stroke 6, 521–524, 1975.

    CAS  PubMed  Google Scholar 

  35. Wu K.K.:Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann. Intern. Med. 88, 7–11, 1978.

    CAS  PubMed  Google Scholar 

  36. Wu K.K.:Hyperactive platelets in thrombotic cerebro-vascular diseases: indication for anti-Platelet therapy. Simposio Internazionale Istituto M. Negri: Prevenzione e Trattamento Farmacologico delle CVP croniche, Milan 2–4, May, 1979.

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the National Research Council, Special Project on Preventive Medicine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Marinis, M., Fieschi, C., Prencipe, M. et al. Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks. Ital J Neuro Sci 1, 163–169 (1979). https://doi.org/10.1007/BF02335846

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02335846

Key-Words

Navigation